Clinical trial
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia…
NCT00186381 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186381 |
|---|---|
| Title | Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission |
| Official title | Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Myelocytic, Acute, Blood and Marrow Transplant (BMT) |
| Intervention type | Procedure |
| Interventions | high dose chemotherapy then autologous hematopoietic cell transplant |
| Enrollment | 200 |
| Start date | Nov 1, 1995 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 27, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: